Clinical Trial Update: Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 results from the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI-2D) trial evaluating revascularization strategies (CABG vs …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Pittsburgh | Conditions: Coronary Disease, Cardiovascular Diseases | Phase 3 | Status: COMPLETED | Results posted: 2011-05-12